TTNP

Titan Pharmaceuticals

Delisted

TTNP was delisted on the 1st of October, 2025.

22 hedge funds and large institutions have $1.76M invested in Titan Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$53K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$68.6K
2 +$53K
3 +$39K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$11.3K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$3.4K

Top Sellers

1 -$38K
2 -$18K
3 -$16K
4
Morgan Stanley
Morgan Stanley
New York
-$4K
5
BlackRock
BlackRock
New York
-$3.77K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1K
27
$2
28
29
30